Editorial: New insights: developments in laboratory testing for the diagnosis and monitoring of endocrine related disorders and metabolic disease

Other OA: gold CC-BY-4.0
⚙ AI-generated summary by qwen3.7-flash+body, 2026-08-18 ⓘ

This editorial outlines new insights and developments in laboratory testing for the diagnosis and monitoring of endocrine-related disorders and metabolic disease.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-18 · read from full text ⓘ

This editorial outlines recent advancements in laboratory testing methodologies for diagnosing and monitoring endocrine-related disorders and metabolic diseases. The authors, including one employed by a commercial diagnostic company, discuss the evolving landscape of clinical assays without presenting original primary research data. The text serves as a commentary on current trends and improvements in biochemical analysis rather than a detailed study of specific patient populations or outcomes. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 693 characters · extracted from epmc-fulltextxml · 3 sections · click to expand

Author

VG: Conceptualization, Writing – original draft, Writing – review & editing. PT: Writing – review & editing.

Conflict

Author PT was employed by company Quest Diagnostics. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’S

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: epmc-fulltextxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00
pubmed
last seen: 2026-10-08T21:47:03.166880+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC